ArticleJournal of experimental & clinical cancer research : CR2019

Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.

Ning Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.